Atria Investments’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.45M Buy
374,417
+41,680
+13% +$1.05M 0.09% 220
2026
Q1
$8.43M Buy
332,737
+14,558
+5% +$370K 0.09% 231
2025
Q4
$8.1M Buy
318,179
+113,453
+55% +$2.89M 0.09% 240
2025
Q3
$5.22M Buy
204,726
+638
+0.3% +$16.2K 0.06% 377
2025
Q2
$5.19M Buy
204,088
+2,044
+1% +$51.5K 0.06% 370
2025
Q1
$5.1M Buy
202,044
+10,351
+5% +$259K 0.07% 369
2024
Q4
$4.77M Buy
191,693
+88,724
+86% +$2.23M 0.06% 363
2024
Q3
$2.63M Buy
102,969
+5,863
+6% +$148K 0.03% 577
2024
Q2
$2.41M Buy
97,106
+5,439
+6% +$134K 0.03% 583
2024
Q1
$2.28M Buy
91,667
+5,767
+7% +$144K 0.03% 598
2023
Q4
$2.16M Buy
+85,900
New +$2.09M 0.03% 568

Other funds holding IBDT

Atria Investments's IBDT Position: Q2 2026 in Review

Atria Investments increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 13% in Q2 2026, buying an estimated $1.05M and bringing the position to 374,417 shares worth $9.45M. The position accounts for 0.09% of the portfolio, ranked #220.

Atria Investments first reported a position in IBDT in Q4 2023 and has held it in 11 quarters since. 436 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Atria Investments held 374,417 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $9.45M as of Q2 2026.
  • Atria Investments bought 41,680 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $1.05M.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.09% of Atria Investments's portfolio in Q2 2026, its #220 holding.
  • Atria Investments first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 436 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.